InvestorsHub Logo
Followers 116
Posts 1878
Boards Moderated 0
Alias Born 11/22/2017

Re: None

Thursday, 11/22/2018 3:08:20 PM

Thursday, November 22, 2018 3:08:20 PM

Post# of 704632
SNO data 2018 DCVAX-L trial.

3 year survival rate of the final 108 patients who had surgery between between September 2014 and August 2015 =39,81%

108 patients: probably 83 treatment and 25 placebo.

65 patients died before 36 months.
108 – 65 = 43 patients made it to 36 months.
43/108= 39.81%

NOOT:All 7 patients censored on the OS curve 2017 (all MGMT Methylated) made it to 36 months.

Source: The Journal and SNO presentation.
IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News